Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
787 studies found for:    pharmacogenomics OR pharmacogenetics
Show Display Options
Download search resultsDownload the search results for:
pharmacogenomics OR pharmacogenetics (787 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Completed Implementation of a Personalized Medicine (Pharmacogenomics) Service in a Community Pharmacy
Conditions: Stroke;   Transient Ischemic Attack;   Myocardial Infarction
Intervention: Other: Pharmacogenomics testing for clopidogrel responsiveness
2 Active, not recruiting Pharmacogenomics and Effective Treatment With Clopidogrel
Condition: Pharmacogenomics
Intervention: Genetic: Pharmacogenomics
3 Not yet recruiting A Prospective Trial to Assess Cost and Clinical Outcomes of a Clinical Pharmacogenomic Program
Condition: Adverse Drug Reaction
Intervention: Device: Pharmacogenetic Intervention Arm (pharmacogenetic testing)
4 Completed
Has Results
Applying Pharmacogenetic Algorithms to Individualize Dosing of Warfarin
Condition: Thromboembolism
Interventions: Genetic: IWPC adapted genotype-guided dosing algorithm for warfarin;   Genetic: Modified IWPC genetic-guided warfarin dosing algorithm;   Other: Standard of care treatment
5 Completed Antidepressant Treatment of Mexican-Americans: UCLA Pharmacogenetics and Pharmacogenomics Research Group
Conditions: Major Depressive Disorder;   Major Depression;   Unipolar Depression
Intervention: Drug: fluoxetine or desipramine
6 Not yet recruiting Pharmacogenomics Registry to Assess Clinical Utility
Condition: Drug Side Effects
Intervention:
7 Recruiting Applying Pharmacogenetics to Warfarin Dosing in Chinese Patients
Conditions: Atrial Fibrillation;   Deep Vein Thrombosis;   Pulmonary Embolism;   Heart Valve Disease
Interventions: Other: Genotype-guided warfarin dosing;   Other: Non-genotype guided warfarin dosing
8 Completed
Has Results
Comparison of Warfarin Dosing Using Decision Model Versus Pharmacogenetic Algorithm
Conditions: Atrial Fibrillation;   Pulmonary Embolism;   Deep Vein Thrombosis
Intervention: Genetic: Warfarin Dose based on pharmacogenetics
9 Active, not recruiting Pharmacogenetic Testing in Primary Care
Condition: Pharmacogenetic Testing
Intervention:
10 Completed Renal Function and Pharmacogenetics in Renal Transplant Recipients Converted From Tac BID to Tac OD
Conditions: Real Function Post Conversion From Prograf to Advagraf;   Examin Ethnicity and Pharmacogenetics of the Cohort Requiring Dose Adjustment Post-conversion
Intervention:
11 Completed Clinical and Economic Impact of an Electronic Medical Record Interfaced Decision Support System Reinforced With Patient Specific Pharmacogenetic Data for Minimizing Severe Drug-Drug Interactions
Condition: Healthcare
Intervention: Other: DDI+ System and Pharmacogenetic Data
12 Recruiting Utility of PharmacoGenomics for Reducing Adverse Drug Effects
Condition: Genetics of Drug Metabolism
Intervention:
13 Recruiting Pharmacogenomics of Mood Stabilizer Response in Bipolar Disorder (PGBD)
Condition: Bipolar Affective Disorder
Intervention: Drug: Mood stabilizer treatment
14 Unknown  Validation of Pharmacogenetics Plus Drug Combination Guided Initial Tacrolimus Dosage in Renal Transplant Recipients
Condition: Renal Transplantation
Interventions: Other: drug (tacrolimus and SchE) and genetics;   Drug: tacrolimus
15 Unknown  Pharmacogenomics Studies of Antidepressants
Conditions: Major Depressive Disorder;   Antidepressive Agents;   Pharmacogenetics;   Venlafaxine;   Fluoxetine
Interventions: Drug: Venlafaxine;   Drug: Fluoxetine
16 Completed Pharmacogenomics Validation for Imatinib in Chronic Myeloid Leukemia
Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Intervention:
17 Completed Pharmacogenomic of Atazanavir/Efavirenz (ATV/EFV)
Condition: HIV Infections
Intervention:
18 Completed Pharmacogenetics of Warfarin in Puerto Ricans.
Conditions: Atrial Fibrillation;   Deep Vein Thrombosis;   Cardiac Valvular Insufficiency;   Antiphospholipid Syndrome;   Coagulopathy
Intervention:
19 Unknown  Development of Pharmacogenomic Method to Predict Antidepressant Responsiveness
Conditions: Depression;   Antidepressant Drug Adverse Reaction
Interventions: Drug: SSRI class antidepressant;   Drug: non-SSRI class antidepressant
20 Unknown  Pharmacogenomics of Anti-TNF (Anti-tumor Necrosis Factor) Treatment in Patients With Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years